SAB Biotherapeutics Growth Metrics (2021-2025) | SABS

Growth Metrics Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M-0.25M1.67M1.90M
EBITDA Margin Growth (3y) -0.12M-0.39M-0.87M1.55M1.52M2.95M
EBITDA Margin (QoQ) -0.00M-0.00M-0.00M959.00-0.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M2.42M-0.04M1.42M
EBIT Margin Growth (1y) -0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M-0.25M1.67M1.90M
EBIT Margin Growth (3y) -0.12M-0.39M-0.87M1.55M1.52M2.95M
EBIT Margin (QoQ) -0.00M-0.00M-0.00M959.00-0.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M2.42M-0.04M1.42M
EBT Margin Growth (1y) 81.00-0.01M-0.02M-0.03M-0.13M-0.80M-0.02M-0.71M0.07M0.53M-0.12M1.60M1.80M
EBT Margin Growth (3y) -0.05M-0.28M-0.86M1.55M1.53M2.81M
EBT Margin (QoQ) -0.00M-0.00M-0.01M0.01M-0.01M-0.01M-0.02M-0.09M-0.68M0.76M-0.71M0.70M-0.23M2.42M-0.03M1.27M
Enterprise Value Growth (1y) -213.59%-11.33%-62.39%22.50%61.95%41.72%53.21%70.89%-275.93%-237.34%-380.11%-1,154.58%63.30%70.83%84.69%-264.39%
Enterprise Value Growth (3y) -64.92%-29.84%-53.94%-41.46%19.33%16.92%29.94%-136.97%
Enterprise Value (QoQ) -59.62%49.16%-5.06%-267.83%43.33%25.85%49.86%-80.59%13.20%40.47%68.80%-2,232.16%22.11%15.28%18.48%31.77%38.10%55.54%-1,840.66%
FCF Margin Growth (1y) -0.01M-0.00M-0.02M-0.00M-0.02M-0.57M-0.02M-0.44M-0.09M0.28M-0.39M1.24M1.41M
FCF Margin Growth (3y) -0.12M-0.29M-0.83M1.13M1.12M3.04M
FCF Margin (QoQ) -0.01M0.01M-0.01M-0.00M0.00M-0.01M0.01M-0.02M-0.55M0.53M-0.40M0.33M-0.18M1.96M-0.01M1.90M
Interest Coverage Ratio Growth (1y) -960.35%-138.00%-117.63%19.12%13.97%6.38%30.92%-170.40%-86.15%-27.41%-89.77%41.73%-3.82%-38.06%-102.08%
Interest Coverage Ratio Growth (3y) -150.82%-41.59%-41.83%-8.42%-18.47%-18.09%-38.37%
Interest Coverage Ratio (QoQ) -456.52%-31.62%-118.16%15.96%1.38%-20.36%18.92%10.60%-7.32%11.19%-217.34%38.46%26.55%-32.28%2.56%-9.65%2.33%-93.64%
Net Margin Growth (1y) 2.00-0.01M-0.02M-0.03M-0.13M-0.80M-0.02M-0.71M0.07M0.53M-0.24M0.80M1.85M
Net Margin Growth (3y) -0.05M-0.28M-0.98M0.75M1.58M2.81M
Net Margin (QoQ) -0.00M-0.00M-0.01M0.01M-0.01M-0.01M-0.02M-0.09M-0.68M0.76M-0.71M0.70M-0.23M1.74M0.82M1.22M
Operating Margin Growth (1y) -0.01M-0.01M-0.02M-0.03M-0.12M-0.75M-0.02M-0.58M0.01M0.37M-0.25M1.67M1.90M
Operating Margin Growth (3y) -0.12M-0.39M-0.87M1.55M1.52M2.95M
Operating Margin (QoQ) -0.00M-0.00M-0.00M959.00-0.00M-0.01M-0.01M-0.09M-0.63M0.72M-0.58M0.50M-0.27M2.42M-0.04M1.42M
Return on Assets Growth (1y) -35.00-19.00-34.00-44.00-45.00-39.006.0014.006.009.00-42.00-59.0039.00
Return on Assets Growth (3y) -74.00-49.00-70.00-89.000.00M
Return on Assets (QoQ) -13.00-6.00-7.00-10.004.00-22.00-17.00-11.0010.0024.00-9.00-18.0012.00-27.00-26.0080.00
Return on Capital Employed Growth (1y) -60.00-52.00-54.00-46.00-5.0029.0028.0014.00-21.00-74.00-101.0061.00
Return on Capital Employed Growth (3y) -86.00-97.00-127.0028.00
Return on Capital Employed (QoQ) -19.00-14.00-21.00-6.00-11.00-16.00-14.0035.0023.00-17.00-28.001.00-30.00-44.00133.00
Return on Equity Growth (1y) -51.00-14.00-54.00-83.00-89.00-56.0025.0051.0046.0012.00-90.00-163.0062.00
Return on Equity Growth (3y) -95.00-57.00-118.00-195.0018.00
Return on Equity (QoQ) -31.003.00-5.00-17.005.00-37.00-35.00-23.0039.0044.00-9.00-28.006.00-58.00-82.00196.00
Return on Sales Growth (1y) 0.00M-59.00-169.00-259.00-0.00M-0.01M-205.00-0.01M733.000.01M-0.00M-0.00M0.02M0.02M0.03M
Return on Sales Growth (3y) -540.00-0.00M-0.00M-0.01M0.02M0.02M0.03M
Return on Sales (QoQ) -24.00-12.00-77.00113.00-84.00-122.00-166.00-902.00-0.01M0.01M-0.01M0.01M-0.00M-225.00-0.01M0.02M-291.000.01M